Is ProKidney Corp Stock a Good Investment?
ProKidney Corp Investment Advice | PROK |
- Examine ProKidney Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research ProKidney Corp's leadership team and their track record. Good management can help ProKidney Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact ProKidney Corp's business and its evolving consumer preferences.
- Compare ProKidney Corp's performance and market position to its competitors. Analyze how ProKidney Corp is positioned in terms of product offerings, innovation, and market share.
- Check if ProKidney Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about ProKidney Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in ProKidney Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ProKidney Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine ProKidney Corp Stock
Researching ProKidney Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.54. ProKidney Corp had not issued any dividends in recent years. The entity had 1:1 split on the 12th of July 2022.
To determine if ProKidney Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ProKidney Corp's research are outlined below:
| ProKidney Corp had very high historical volatility over the last 90 days | |
| ProKidney Corp may become a speculative penny stock | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (135.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
ProKidney Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ProKidney Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ProKidney Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact ProKidney Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises ProKidney Corp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-10 | 2024-03-31 | -0.18 | -0.16 | 0.02 | 11 | ||
2023-11-14 | 2023-09-30 | -0.16 | -0.18 | -0.02 | 12 | ||
2024-03-22 | 2023-12-31 | -0.17 | -0.09 | 0.08 | 47 | ||
2022-11-14 | 2022-09-30 | -0.24 | -0.13 | 0.11 | 45 | ||
2023-03-28 | 2022-12-31 | -0.24 | -0.11 | 0.13 | 54 | ||
2023-05-11 | 2023-03-31 | -0.39 | -0.16 | 0.23 | 58 | ||
2023-08-10 | 2023-06-30 | -0.39 | -0.14 | 0.25 | 64 |
Know ProKidney Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ProKidney Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProKidney Corp backward and forwards among themselves. ProKidney Corp's institutional investor refers to the entity that pools money to purchase ProKidney Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 227.2 K | Bank Of New York Mellon Corp | 2024-09-30 | 190.5 K | Goldman Sachs Group Inc | 2024-09-30 | 188.1 K | Amundi | 2024-09-30 | 156 K | Barclays Plc | 2024-09-30 | 146.3 K | Alps Advisors Inc | 2024-09-30 | 97.4 K | Rhumbline Advisers | 2024-09-30 | 90.4 K | Alliancebernstein L.p. | 2024-09-30 | 84.2 K | Citigroup Inc | 2024-09-30 | 75.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 14.3 M | Suvretta Capital Management, Llc | 2024-09-30 | 12.3 M |
ProKidney Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.81 B.Market Cap |
|
ProKidney Corp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.34) | (0.36) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | 0.03 | 0.03 |
Determining ProKidney Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if ProKidney Corp is a good buy. For example, gross profit margin measures ProKidney Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ProKidney Corp's profitability and make more informed investment decisions.
Evaluate ProKidney Corp's management efficiency
ProKidney Corp has return on total asset (ROA) of (0.2037) % which means that it has lost $0.2037 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3134) %, meaning that it created substantial loss on money invested by shareholders. ProKidney Corp's management efficiency ratios could be used to measure how well ProKidney Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 0.03 this year, although the value of Return On Tangible Assets will most likely fall to (0.08). At this time, ProKidney Corp's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 507.8 M this year, although the value of Change To Liabilities will most likely fall to about 843.4 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.71 | 5.99 | |
| Tangible Book Value Per Share | 5.71 | 5.99 | |
| Enterprise Value Over EBITDA | (0.33) | (0.34) | |
| Price Book Value Ratio | (0.10) | (0.11) | |
| Enterprise Value Multiple | (0.33) | (0.34) | |
| Price Fair Value | (0.10) | (0.11) | |
| Enterprise Value | 48.3 M | 50.7 M |
The management team at ProKidney Corp has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 1.305 |
Basic technical analysis of ProKidney Stock
As of the 22nd of January, ProKidney Corp holds the Semi Deviation of 6.95, coefficient of variation of 2500.51, and Risk Adjusted Performance of 0.0424. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProKidney Corp, as well as the relationship between them.ProKidney Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProKidney Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProKidney Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ProKidney Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand ProKidney Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing ProKidney Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0424 | |||
| Market Risk Adjusted Performance | 0.4284 | |||
| Mean Deviation | 4.72 | |||
| Semi Deviation | 6.95 | |||
| Downside Deviation | 7.23 | |||
| Coefficient Of Variation | 2500.51 | |||
| Standard Deviation | 6.25 | |||
| Variance | 39.12 | |||
| Information Ratio | 0.0342 | |||
| Jensen Alpha | 0.2249 | |||
| Total Risk Alpha | 0.0439 | |||
| Sortino Ratio | 0.0296 | |||
| Treynor Ratio | 0.4184 | |||
| Maximum Drawdown | 33.89 | |||
| Value At Risk | (8.92) | |||
| Potential Upside | 8.43 | |||
| Downside Variance | 52.26 | |||
| Semi Variance | 48.27 | |||
| Expected Short fall | (4.46) | |||
| Skewness | (0.61) | |||
| Kurtosis | 1.51 |
| Risk Adjusted Performance | 0.0424 | |||
| Market Risk Adjusted Performance | 0.4284 | |||
| Mean Deviation | 4.72 | |||
| Semi Deviation | 6.95 | |||
| Downside Deviation | 7.23 | |||
| Coefficient Of Variation | 2500.51 | |||
| Standard Deviation | 6.25 | |||
| Variance | 39.12 | |||
| Information Ratio | 0.0342 | |||
| Jensen Alpha | 0.2249 | |||
| Total Risk Alpha | 0.0439 | |||
| Sortino Ratio | 0.0296 | |||
| Treynor Ratio | 0.4184 | |||
| Maximum Drawdown | 33.89 | |||
| Value At Risk | (8.92) | |||
| Potential Upside | 8.43 | |||
| Downside Variance | 52.26 | |||
| Semi Variance | 48.27 | |||
| Expected Short fall | (4.46) | |||
| Skewness | (0.61) | |||
| Kurtosis | 1.51 |
Consider ProKidney Corp's intraday indicators
ProKidney Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ProKidney Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 27124.03 | |||
| Daily Balance Of Power | (0.86) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 1.74 | |||
| Day Typical Price | 1.72 | |||
| Price Action Indicator | (0.13) | |||
| Period Momentum Indicator | (0.12) |
ProKidney Stock media impact
Far too much social signal, news, headlines, and media speculation about ProKidney Corp that are available to investors today. That information is available publicly through ProKidney media outlets and privately through word of mouth or via ProKidney internal channels. However, regardless of the origin, that massive amount of ProKidney data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProKidney Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProKidney Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProKidney Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProKidney Corp alpha.
ProKidney Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ProKidney Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ProKidney Corp Corporate Management
| Ulrich Ernst | EVP Technology | Profile | |
| Aparna MD | VP Development | Profile | |
| Joseph MD | VP Devel | Profile | |
| Ashley Johns | VP Operations | Profile | |
| Carla Poulson | Chief Officer | Profile | |
| James CPA | Chief Officer | Profile | |
| Richard Williams | Senior Technology | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between ProKidney Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.